These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 31619219)

  • 21. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study.
    Carugati M; Aliberti S; Sotgiu G; Blasi F; Gori A; Menendez R; Encheva M; Gallego M; Leuschner P; Ruiz-Buitrago S; Battaglia S; Fantini R; Pascual-Guardia S; Marin-Corral J; Restrepo MI;
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1513-1525. PubMed ID: 32242314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updates on community acquired pneumonia management in the ICU.
    Nair GB; Niederman MS
    Pharmacol Ther; 2021 Jan; 217():107663. PubMed ID: 32805298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
    Ioachimescu OC; Ioachimescu AG; Iannini PB
    Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired Pneumonia.
    Egger ME; Myers JA; Arnold FW; Pass LA; Ramirez JA; Brock GN
    BMC Med Inform Decis Mak; 2016 Mar; 16():34. PubMed ID: 26976388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia.
    Rossio R; Franchi C; Ardoino I; Djade CD; Tettamanti M; Pasina L; Salerno F; Marengoni A; Corrao S; Marcucci M; Peyvandi F; Biganzoli EM; Nobili A; Mannucci PM;
    Eur J Intern Med; 2015 Jun; 26(5):330-7. PubMed ID: 25898778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU.
    Restrepo MI; Mortensen EM; Velez JA; Frei C; Anzueto A
    Chest; 2008 Mar; 133(3):610-7. PubMed ID: 17989157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia.
    Umeki K; Tokimatsu I; Yasuda C; Iwata A; Yoshioka D; Ishii H; Shirai R; Kishi K; Hiramatsu K; Matsumoto B; Kadota J
    Respirology; 2011 Jul; 16(5):856-61. PubMed ID: 21545370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia.
    Martin-Loeches I; Lisboa T; Rodriguez A; Putensen C; Annane D; Garnacho-Montero J; Restrepo MI; Rello J
    Intensive Care Med; 2010 Apr; 36(4):612-20. PubMed ID: 19953222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CURB-65 and SMRT-CO in the prediction of early transfers to the intensive care unit among patients with community-acquired pneumonia initially admitted to a general ward.
    Huaman MA; Diaz-Kuan A; Hegab S; Brar I; Kaatz S
    J Hosp Med; 2011 Nov; 6(9):513-8. PubMed ID: 22042735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for severe community-acquired pneumonia in the western world.
    Vegelin AL; Bissumbhar P; Joore JC; Lammers JW; Hoepelman IM
    Neth J Med; 1999 Sep; 55(3):110-7. PubMed ID: 10509069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of deviation from guidelines on the outcome of community-acquired pneumonia.
    Menéndez R; Ferrando D; Vallés JM; Vallterra J
    Chest; 2002 Aug; 122(2):612-7. PubMed ID: 12171840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Etiology and outcome of community-acquired pneumonia in relation to age and severity in hospitalized adult patients].
    Takayanagi N; Hara K; Tokunaga D; Takaku Y; Minagawa S; Tsuchiya Y; Hijikata N; Yamaji T; Saito H; Ubukata M; Kurashima K; Yanagisawa T; Sugita Y
    Nihon Kokyuki Gakkai Zasshi; 2006 Dec; 44(12):906-15. PubMed ID: 17233386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic treatment outcomes in community-acquired pneumonia.
    Çilli A; Sayıner A; Çelenk B; Şakar Coşkun A; Kılınç O; Hazar A; Aktaş Samur A; Taşbakan S; Waterer GW; Havlucu Y; Kılıç Ö; Tokgöz F; Bilge U
    Turk J Med Sci; 2018 Aug; 48(4):730-736. PubMed ID: 30119147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.
    McCabe C; Kirchner C; Zhang H; Daley J; Fisman DN
    Arch Intern Med; 2009 Sep; 169(16):1525-31. PubMed ID: 19752411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia.
    Malone DC; Shaban HM
    Ann Pharmacother; 2001 Oct; 35(10):1180-5. PubMed ID: 11675841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.
    Frei CR; Jaso TC; Mortensen EM; Restrepo MI; Raut MK; Oramasionwu CU; Ruiz AD; Makos BR; Ruiz JL; Attridge RT; Mody SH; Fisher A; Schein JR
    Curr Med Res Opin; 2009 Apr; 25(4):859-68. PubMed ID: 19231913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT).
    Wiersinga WJ; Bonten MJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; Degener JE; van de Garde EMW; Verheij TJ; Sachs APE; Prins JM
    Neth J Med; 2018 Jan; 76(1):4-13. PubMed ID: 29380739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minor criteria of Infectious Disease Society Of America/American Thoracic Society for severe community-acquired pneumonia can predict delayed treatment response.
    Park SY; Park S; Lee MG; Kim DG; Suh GY; Kim C; Lee CY; Park YB; Jung KS
    J Korean Med Sci; 2012 Aug; 27(8):907-13. PubMed ID: 22876058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved survival among ICU-hospitalized patients with community-acquired pneumonia by unidentified organisms: a multicenter case-control study.
    Rello J; Diaz E; Mañez R; Sole-Violan J; Valles J; Vidaur L; Zaragoza R; Gattarello S;
    Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):123-130. PubMed ID: 27655267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.